These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 8414015)
21. Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations: a multicenter, double-blind, randomized, placebo-controlled trial. Tolcapone Fluctuator Study Group I. Kurth MC; Adler CH; Hilaire MS; Singer C; Waters C; LeWitt P; Chernik DA; Dorflinger EE; Yoo K Neurology; 1997 Jan; 48(1):81-7. PubMed ID: 9008498 [TBL] [Abstract][Full Text] [Related]
22. Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review. Wirdefeldt K; Odin P; Nyholm D CNS Drugs; 2016 May; 30(5):381-404. PubMed ID: 27138916 [TBL] [Abstract][Full Text] [Related]
23. Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients. Antonini A; Fung VS; Boyd JT; Slevin JT; Hall C; Chatamra K; Eaton S; Benesh JA Mov Disord; 2016 Apr; 31(4):530-7. PubMed ID: 26817533 [TBL] [Abstract][Full Text] [Related]
24. Clinical experience with duodenal infusions of levodopa for the treatment of motor fluctuations in Parkinson's disease. Sage JI; Sonsalla PK; McHale DM; Heikkila RE; Duvoisin RC Adv Neurol; 1990; 53():383-6. PubMed ID: 2122646 [No Abstract] [Full Text] [Related]
25. Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group. Block G; Liss C; Reines S; Irr J; Nibbelink D Eur Neurol; 1997; 37(1):23-7. PubMed ID: 9018028 [TBL] [Abstract][Full Text] [Related]
26. Controlled-release carbidopa-levodopa (Sinemet) in combination with standard Sinemet in advanced Parkinson's disease. Mark MH; Sage JI Ann Clin Lab Sci; 1989; 19(2):101-6. PubMed ID: 2665626 [TBL] [Abstract][Full Text] [Related]
27. Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease. LeWitt PA; Huff FJ; Hauser RA; Chen D; Lissin D; Zomorodi K; Cundy KC Mov Disord; 2014 Jan; 29(1):75-82. PubMed ID: 24339234 [TBL] [Abstract][Full Text] [Related]
28. Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease. Nyholm D Expert Rev Neurother; 2006 Oct; 6(10):1403-11. PubMed ID: 17078781 [TBL] [Abstract][Full Text] [Related]
30. [Management of complications related to intraduodenal infusion of levodopa/carbidopa in patients with Parkinson's disease]. Santos-Garcia D; de Deus T; Lopez-Pazos E; Macias-Arribi M; Llaneza-Gonzalez MA; Echarri-Piudo A; Carpintero P; de la Fuente-Fernandez R Rev Neurol; 2014 Jun; 58(11):505-15. PubMed ID: 24861226 [TBL] [Abstract][Full Text] [Related]
31. Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease. Pahwa R; Lyons KE; Hauser RA; Fahn S; Jankovic J; Pourcher E; Hsu A; O'Connell M; Kell S; Gupta S; Parkinsonism Relat Disord; 2014 Feb; 20(2):142-8. PubMed ID: 24055014 [TBL] [Abstract][Full Text] [Related]
32. Prolonged serum levodopa levels with controlled-release carbidopa-levodopa in the treatment of Parkinson's disease. Hutton JT; Albrecht JW; Román GC; Kopetzky MT Arch Neurol; 1988 Jan; 45(1):55-7. PubMed ID: 3276299 [TBL] [Abstract][Full Text] [Related]
33. Randomized double-blind cross-over study of Sinemet-controlled release (CR4 50/200) versus Sinemet 25/100 in Parkinson's disease. Lieberman A; Gopinathan G; Miller E; Neophytides A; Baumann G; Chin L Eur Neurol; 1990; 30(2):75-8. PubMed ID: 2340838 [TBL] [Abstract][Full Text] [Related]
34. Clinical and pharmacokinetic comparison of oral and duodenal delivery of levodopa/carbidopa in patients with Parkinson's disease with a fluctuating response to levodopa. Deleu D; Ebinger G; Michotte Y Eur J Clin Pharmacol; 1991; 41(5):453-8. PubMed ID: 1761073 [TBL] [Abstract][Full Text] [Related]
35. Sinemet CR in Parkinson's disease. Pfeiffer RF; Wilken KE; Glaeske CS; Hofman R Nebr Med J; 1991 Jan; 76(1):8-10. PubMed ID: 1997878 [TBL] [Abstract][Full Text] [Related]
36. Long-term efficacy of controlled-release carbidopa/levodopa in patients with advanced Parkinson's disease. Mark MH; Sage JI Ann Clin Lab Sci; 1989; 19(6):415-21. PubMed ID: 2690730 [TBL] [Abstract][Full Text] [Related]
37. Intraduodenal infusion of a water-based levodopa dispersion for optimisation of the therapeutic effect in severe Parkinson's disease. Bredberg E; Nilsson D; Johansson K; Aquilonius SM; Johnels B; Nyström C; Paalzow L Eur J Clin Pharmacol; 1993; 45(2):117-22. PubMed ID: 8223831 [TBL] [Abstract][Full Text] [Related]
38. [Continuous treatment with levodopa of Parkinson disease]. Lundqvist C; Nystedt T; Reiertsen O; Grotli R; Beiske AG Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2638-40. PubMed ID: 16215609 [TBL] [Abstract][Full Text] [Related]